日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors

TIMEPOINT 是一项将 MTL-CEBPA 与帕博利珠单抗联合使用的 1 期研究,该研究支持 MTL-CEBPA 在实体瘤中的免疫调节作用。

Ruth Plummer ,Mikael H Sodergren ,Rose Hodgson ,Bríd M Ryan ,Nina Raulf ,Joanna P Nicholls ,Vikash Reebye ,Jon Voutila ,Laura Sinigaglia ,Tim Meyer ,David J Pinato ,Debashis Sarker ,Bristi Basu ,Sarah Blagden ,Natalie Cook ,Thomas R Jeffrey Evans ,Jeffrey Yachnin ,Cheng E Chee ,Daneng Li ,Anthony El-Khoueiry ,Maria Diab ,Kai-Wen Huang ,Madhava Pai ,Duncan Spalding ,Thomas Talbot ,Marcus S Noel ,Bridget Keenan ,Devalingam Mahalingam ,Min-Sun Song ,Mélanie Grosso ,Denis Arnaud ,Aurelie Auguste ,Dimitris Zacharoulis ,Jan Storkholm ,Iain McNeish ,Robert Habib ,John J Rossi ,Nagy A Habib

Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer

C/EBPα 的上调可抑制髓系细胞的抑制活性并增强小鼠和癌症患者的抗肿瘤反应

Ayumi Hashimoto #, Debashis Sarker #, Vikash Reebye #, Sheba Jarvis, Mikael H Sodergren, Andrew Kossenkov, Emilio Sanseviero, Nina Raulf, Jenni Vasara, Pinelopi Andrikakou, Tim Meyer, Kai-Wen Huang, Ruth Plummer, Cheng E Chee, Duncan Spalding, Madhava Pai, Shahid Khan, David J Pinato, Rohini Sharma,